| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911665 | Lung Cancer | 2005 | 12 Pages |
Abstract
The analysis of circulating DNA or RNA in plasma is a promising non-invasive diagnostic tool, requiring only a limited blood sample. Its wide applicability and potential importance will possibly lead to increasing clinical impact in the near future. However, large prospective clinical studies are needed to validate and standardise any tests for DNA or RNA alteration in plasma or serum of high risk individuals or patients with established lung cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Roy M. Bremnes, Rafael Sirera, Carlos Camps,